表紙
市場調查報告書

IVD (體外診斷用醫藥品) 市場趨勢的摘要

IVD Market Trends Summary

出版商 Kalorama Information 商品編碼 876613
出版日期 內容資訊 英文 31 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
IVD (體外診斷用醫藥品) 市場趨勢的摘要 IVD Market Trends Summary
出版日期: 2019年10月31日內容資訊: 英文 31 Pages
簡介

本報告提供全球IVD (體外診斷用醫藥品) 診斷市場調查,新興市場上市場發展,美國的IVD市場上PAMA的影響,中國的IVD市場上美國關稅的影響,照護現場 (POC) 分子診斷市場,FDA 510 (k) 核准,取得了CLIA Waiver認證或CE標誌產品的新產品,扁虱媒介疾病檢驗的新發展等,目前市場趨勢,最新情形等彙整資料。

簡介

東歐

中東

南美

照護現場 (POC) 分子診斷

新的FDA (美國食品藥物管理局) 核准,CLIA Waiver已認證,CE標誌產品

扁虱媒介疾病

焦蟲病

新開發

  • ChemBio Diagnostics, Inc. (Medford, NY)
  • Cue Health, Inc. (San Diego, CA) and Diassess, Inc. (Emeryville, CA)
  • ChromaCode (Carlsbad, CA)
  • Curetis (Holzgerlingen, Germany)
  • 感染疾病

摘要

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 19-056

This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture.

The topics discussed are the following:

  • The Worldwide IVD Market, 2019-2024
  • Market Developments in Selected Markets - North America, EU15/Western Europe, Eastern Europe, Japan and China
  • Genetic Testing
  • New POC Innovations
  • Cancer Testing and Personalized Medicine
  • Hematology
  • Glucose Monitoring Advancements
  • HbA1c Testing
  • New Developments in Infectious Diseases
  • Cytology - Increasing Molecular Dx Options
  • Blood Bank Markets
  • Synovial Fluid Testing
  • Transplant Diagnostics
  • Tick-Borne Diseases: Babesiosis
  • Parasites
  • Industry Partnerships and Collaborations

Table of Contents

IVD TRENDS 2019: PART II

INTRODUCTION

  • Figure 1-1: The Worldwide IVD Market, 2019 -2024 ($millions)
  • Figure 1-2: Regional Distribution of IVD Market, 2019 (N. America, Europe, Japan,

NORTH AMERICA

EU15/WESTERN EUROPE

EASTERN EUROPE

JAPAN

CHINA

GENETIC TESTING

NEW POC INNOVATIONS

  • CANCER TESTING AND PERSONALIZED MEDICINE
  • HEMATOLOGY
  • GLUCOSE MONITORING ADVANCEMENTS
  • HBA1C TESTING

NEW DEVELOPMENTS IN INFECTIOUS DISEASES

  • Ebola Testing
  • Hepatitis C Testing
  • HIV Testing
  • Molecular Diagnostics Innovations for Infectious Diseases
  • Respiratory Viruses
  • Sepsis
  • STDs.
  • Zika Virus Testing

CYTOLOGY - INCREASING MOLECULAR DX OPTIONS

BLOOD BANK MARKETS

SYNOVIAL FLUID TESTING

TRANSPLANT DIAGNOSTICS

TICK-BORNE DISEASES

  • Babesiosis

PARASITES

LATEST INDUSTRY ACTIVITY

  • Abbott Diagnostics and Intoximeters
  • Agilent Acquires BioTek Instruments
  • Adaptive Biotechnologies and Illumina
  • AroCell AB and Diapharma Group
  • Beckman Coulter and Cytobank
  • BGI Genomics and Pryzm Health
  • CareDx and Cibiltech
  • Exact Sciences Buys Genomic Health
  • Illumina and Qiagen Partnership
  • Invitae and Singular Bio
  • LabCorp Sells Qiagen's Companion Dx
  • NeuMoDx and SelfScreen
  • Meridian Bioscience and GenePOC
  • Qiagen Launches APIS Assay Technologies, Ltd.
  • Qiagen and Inovio Pharmaceuticals
  • Qiagen Collaborates with DiaSorin
  • Thermo Fisher Scientific and HighChem Ltd.
  • Companies Buy to Grow
  • Gene Editing
Back to Top